Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2026-03-20
Summary
Background:
\- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the disease affects them.
Objective:
\- To learn the signs, symptoms, imaging tests, genetic markers, and blood tests that can help identify people with vasculitis and predict what will happen to them over time.
Eligibility:
* People age 3 and older who have or are thought to have vasculitis, or are related to someone with it.
* Healthy volunteers.
Design:
* Participants will be evaluated by a doctor who has expertise caring for patients with vasculitis.
* Participants will give a blood sample. Some will give a urine sample.
* Some participants may have brushings or biopsies taken from the inside lining of the nose.
* Images of participants blood vessels may be taken using scans. For some scans, participants will lie on a table that moves in and out of a cylinder that takes pictures. For some scans, a contrast agent may be injected into an arm vein. Other scans may use a radioactive form of sugar. Healthy minors will not have scans.
* Some participants will answer questionnaires. - Some participants will have their tests done at NIH. Others will have their doctor take the blood, saliva, or cheek swab samples and send them to NIH.
* Some participants will have one visit lasting 1-2 (but sometimes up to 4) days. Some participants may have follow-up visits every 3 - 6 months, indefinitely.
Conditions
- Takayasu's Arteritis
- Giant Cell Arteritis
- Polyarteritis Nodosa
- Relapsing Polychondritis
- ANCA-Associated Vasculitis
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
lead NIH
Principal Investigators
-
Peter C Grayson, M.D. · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eligibility
- Min Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-09-29
- Primary Completion
- 2050-01-01
- Completion
- 2050-01-01
Countries
- United States
Study Locations
More Related Trials
-
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
NCT01063309 ·Status: COMPLETED
-
Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001257 ·Status: TERMINATED
-
PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis
NCT07258524 ·Status: RECRUITING
-
Immune System Related Kidney Disease
NCT00001979 ·Status: RECRUITING
-
Prognostic Value of Anti-Ro52 Antibodies in Connective Tissue Diseases (a-Ro52)
NCT03565601 ·Status: UNKNOWN
-
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
NCT07010250 ·Status: NOT_YET_RECRUITING
-
Pathogenesis of Glomerulosclerosis
NCT00001392 ·Status: COMPLETED
-
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
NCT06605378 ·Status: RECRUITING
-
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
NCT00522002 ·Status: COMPLETED
-
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
NCT04902807 ·Status: RECRUITING
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Epidemiology of SAIDs.
NCT03643809 ·Status: COMPLETED
-
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
NCT06587828 ·Status: RECRUITING
-
Biomarkers for the Progression of IgA Nephropathy
NCT02529722 ·Status: COMPLETED
-
Liver Cirrhosis Network Cohort Study
NCT05740358 ·Status: ACTIVE_NOT_RECRUITING
-
Immunogenetic Mechanisms in Behcet's Disease
NCT01109433 ·Status: TERMINATED
-
IgA-positive Versus IgA-negative Immune Complex Vasculitis
NCT01815190 ·Status: UNKNOWN
-
Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease
NCT03868332 ·Status: UNKNOWN
-
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002 ·Status: RECRUITING
-
Circulating Anti-Beta2-glycoprotein Antibodies and Endothelial Dysfunction
NCT01822990 ·Status: COMPLETED
-
Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
NCT03698071 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Bowel Disease and Thromboembolic Events
NCT05162339 ·Status: COMPLETED
-
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715 ·Status: RECRUITING
-
A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
NCT06322641 ·Status: COMPLETED
-
Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome
NCT04895878 ·Status: COMPLETED